SciSparc (SPRC) Long-Term Investments (2020 - 2025)
SciSparc (SPRC) posted Long-Term Investments of $997000.0 for Q4 2025, up 55.78% sequentially from $640000.0 in Q2 2025, and up 4.73% YoY from $952000.0 in Q4 2024.
SciSparc (SPRC) Long-Term Investments (2020 - 2025) Analysis & Trends
SciSparc has reported Long-Term Investments for 6 years, with the latest figure at $997000.0 in Q4 2025.
- Quarterly Long-Term Investments rose 4.73% year-over-year to $997000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $997000.0 (up 4.73% YoY) and the FY2025 annual result came in at $997000.0, up 4.73% from the prior year.
- Long-Term Investments rose to $997000.0 in Q4 2025 per SPRC's latest filing, from $640000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $1.2 million in Q2 2024 and troughed at -$700000.0 in Q2 2022.
- A 5-year average of $660111.1 and a median of $781000.0 in 2023 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2023 and 2025: Long-Term Investments soared 227.57% in 2023, then slumped 46.49% in 2025.
- Over 5 years, Long-Term Investments stood at $591000.0 in 2021, then changed by 0.0% to $591000.0 in 2022, then surged by 32.15% to $781000.0 in 2023, then rose by 21.9% to $952000.0 in 2024, then rose by 4.73% to $997000.0 in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $997000.0, $640000.0, and $952000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1.77 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.17 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 372.10 Mn |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 997,000.00 |
| Jun 30, 2025 | 640,000.00 |
| Dec 31, 2024 | 952,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Dec 31, 2023 | 781,000.00 |
| Jun 30, 2023 | 893,000.00 |
| Dec 31, 2022 | 591,000.00 |
| Jun 30, 2022 | -700,000.00 |
| Dec 31, 2021 | 591,000.00 |
| Jun 30, 2020 | 742,000.00 |